Symbol Lookup

Tuesday July 28, 2015 3:40 PM ET. Data delayed 15 minutes.
16.35
-1.84 (-10.12%)
Bid/Lots
16.33/2
Ask/Lots
16.45/3
Open/Prev Close
17.97/18.19
Day Range
16.12-17.99
52-Week Range
14.00-24.00
Vol/Avg Daily Vol
204.4K/90.9K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
European ADRs Advance as Mining and Oil Production Stocks Gain
4 hours ago by Midnight Trader
11:14 AM EDT, 07/28/2015 (MT Newswires) -- American depository receipts of European stocks were trading 0.3% higher at 141.81 on the Bank of New York Mellon Europe ADR Index on Tuesday. Gainers in Continental Europe were led by oil and gas produc...
Trinity Biotech Announces Quarter 2 Financial Results Enrolment for the Meritas Troponin ACS Study Now Completed
6 hours ago by GlobeNewswire

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2015.

European ADR Slide as Oil Stocks Edge Lower
11:17AM ET on Friday Jul 17, 2015 by Midnight Trader
11:17 AM EDT, 07/17/2015 (MT Newswires) -- American depository receipts of European stocks were trading 0.3% lower at 145.66 on the Bank of New York Mellon Europe ADR Index on Friday. Decliners in Continental Europe were led by National Bank of G...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2015 Financial Results
10:51AM ET on Friday Jul 17, 2015 by GlobeNewswire

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2015 on Tuesday, July 28, 201...

Company Information

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Trinity Biotech also is a provider of raw materials to the life sciences and research industries globally. Trinity Biotech markets its portfolio of almost 850 products to customers in approximately 100 countries around the world. The primary market for Trinity Biotech's diagnostic products is the Americas (which consists principally of North America and South America). Its products are classified as point-of-care, emergency medicine, clinical laboratory and blood bank screening. The Company markets products under Uni-Gold, Recombigen, Meritas, Captia, MicroTrak, Bartels, MarDx, MarBlot, Premier, Ultra2, ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ.

CONTACT INFORMATION

HeadquartersIDA Business Park
BRAY, Ireland 18
Phone--
Fax--

EXECUTIVE OFFICERS

Executive Chairman of the BoardRonan O'Caoimh
Chief Financial Officer, SecretaryKevin Tansley
Chief Operating Officer, Executive DirectorRory Nealon
Chief Scientific Officer, and Vice President CardiacEric Brouwer
Executive DirectorJames Walsh

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$431.4MBeta0.67
Revenue (TTM)$105.1MEPS$1.22
Shares Out.23.7MBook Value$8.52
Dividend Yield1.35%P/E14.9x
Annual Dividend Rate0.22 USDPrice/Sales (TTM)4.1
Ex-Div Date6/5/15P/Cash Flow (TTM)--
Pay Date7/1/15Operating Margin17.00%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample